Telescope Innovations Corp · CSE:TELI
Telescope Innovations — Investor Presentation (January 2026)
17 slides from Telescope Innovations's investor presentation, January 2026
Slide 1: Driving innovation through intelligent automation
January 2026 Corporate Presentation Driving innovation through intelligent automation CSE : TELI OTCQB : TELIF FSE : J4U Corporate Presentation January 2026 www.telescopeinnovations.com CSE : TELI OTCQB : TELIF FSE : J4U Telescope Innovations Corp. | 1
Slide 2: Disclaimer
January 2026 Corporate Presentation Disclaimer The Presentation is intended for educational and informational purposes only and does not replace independent professional judgment. Statements of fact and opinions expressed are those of the participants individually. The information is not designed to
Slide 3: Telescope develops intelligent automation platforms that accelerate innovation
January 2026 Corporate Presentation Telescope develops intelligent automation platforms that accelerate innovation Telescope reduces R&D, manufacturing, and commercial deployment time and costs for the chemicals, pharmaceutical, and critical minerals industries Artificial Automation & Analytical Int
Slide 4: Global Demand for Lab Innovation
January 2026 Corporate Presentation Global Demand for Lab Innovation Major spending into intelligent automation to accelerate innovation $42B Global R&D investment Governments around the world are Chemicals in the chemicals sector incentivizing major new investments Industry in 20221 to resolve some
Slide 5: The Impact of Intelligent Automation
January 2026 November 2024 Corporate Corporate Presentation Presentation The Impact of Intelligent Automation AI-guided decision making, automated experiments, and automatic analysis are reducing costs and accelerating the time from lab to market by 10 – 100x Conventional Discovery Drug Development
Slide 6: The Telescope Executive Team
January 2026 Corporate Presentation The Telescope Executive Team Prof. Jason Hein Dr. Barry Sharpless Henry Dubina Vaso Vlachos John Kirincic CTO & Director Senior Advisor CEO & Chairman COO CFO Leads one of the largest academic 2-time winner of the Nobel Prize 35 + years experience in General Ms. V
Slide 7: A Specialized Growth Team
January 2026 Corporate Presentation A Specialized Growth Team Our management team combines internationally-recognized science acumen and a track record of value creation Values at Exit (USD) Scientific Achievements Value Creation History Grew and sold provider of analytical instrumentation for parti
Slide 8: The Telescope Business Model
January 2026 Corporate Presentation The Telescope Business Model Contra ct R&D Clients Industry Clients A scalable, three- Conducting contract R&D pronged revenue with strategic clients to solve specific industry problems generation model Telescope World-Class Contract R&D Science Team Revenue A dec
Slide 9: Our Product Portfolio
January 2026 Corporate Presentation Our Product Portfolio IP Portfolio Supported by a foundation of contract research, 3 patents; 1 proof-of-concept Telescope has entered global markets with a flagship Patent I product and has generated a significant pipeline of Strategic Initiatives 5 & 6 Relevant
Slide 10: DirectInject - LC
January 2026 Corporate Presentation DirectInject - LC An intelligent, automated chemical analysis tool. DirectInject-LC accelerates chemistry research & reduces development costs. Accelerating research through intelligent automation Recurring Revenue Accessories, services, and software licenses prov
Slide 11: Global Distribution Strategy
January 2026 Corporate Presentation Global Distribution Strategy Leveraging international GLOBAL DISTRIBUTION distribution partners to Telescope has signed a global distribution agreement with Mettler Toledo (NYSE: MTD), a global supplier of accelerate the adoption of analytical precision instrument
Slide 12: Self-Driving Labs
January 2026 Corporate Presentation Self-Driving Labs Telescope is developing self-driving labs SELF-DRIVING LABS that leverage robotics, analytical Accelerating the transition of technology, and AI control software to rapidly optimize experiments novel chemicals, materials, or processes from discov
Slide 13: Process technology developer: lithium technology portfolio
December 2025 Corporate Presentation TELESCOPE IS A PROCESS TECHNOLOGY DEVELOPER: OUR FOCUS IS ON FLOW SHEET SIMPLIFICATION TO PRODUCE BATTERY MATERIALS MORE EFFICIENTLY OUR LITHIUM TECHNOLOGY PORTFOLIO INCLUDES: Lithium carbonate purification: Lithium sulfide manufacturing: Battery recycling: Reage
Slide 14: Intellectual Property Licensing - Example
January 2026 Corporate Presentation Intellectual Property Licensing - Example Telescope has developed and is licensing a process for purification of Battery Grade Lithium Carbonate using Automation, In-Situ Analytics and AI driven Optimization Reduce Need for Feedstock Polishing Save 15% on Plant Ca
Slide 15: Global Customer & Partner Network
January 2026 December 2025 Corporate Corporate Presentation Presentation Global Customer & Partner Network Partnering with global enterprises to accelerate distribution, development, and R&D funding Contract Research Clients Pharmaceutical Funding & Academic & Product Development Partners Partners P
Slide 16: Capital Structure
January 2026 Corporate Presentation Capital Structure Telescope leverages AI, robotics, and Share Capitalization Dollar fig ures in CAD advanced data analysis to make research faster, more precise, and Shares Outstanding MM 80.8 more innovative Held by Directors/Officers % 18% A Globally-Scalable In
Slide 17: Driving innovation through intelligent automation
Driving innovation through intelligent automation CSE : TELI OTCQB : TELIF FSE : J4U Contact Investors@telescopeinn.com www.telescopeinnovations.com
Telescope Innovations — Investor Presentation (January 2026) on 6ix